期刊文献+

ABCC8、CHFR、BMP3B、LOX、PRSS21和RASSF1A基因启动子的甲基化状态可能与3种乳腺癌细胞株对5-FU的敏感性相关 被引量:5

The methylation status of ABCC8,CHFR,BMP3B,LOX,PRSS21,and RASSF1A promoters correlate with the sensitivity of three breast cancer cell strains to 5-FU
下载PDF
导出
摘要 目的:寻找与乳腺癌细胞株间药物敏感性差异相关的基因启动子CpG岛甲基化异常,为DNA甲基化异常作为临床化疗敏感性预测手段提供依据。方法:用MTT法测定3种乳腺癌细胞株(Bcap-37、T47D和ZR-75-30)对9种化疗药物(紫杉醇、紫杉特尔、长春瑞宾、5-氟尿嘧啶(5-FU)、双氟去氧胞苷、表阿霉素、丝裂霉素、依立替康和顺铂)的敏感性;同时用甲基化特异性PCR检测23个基因在3种乳腺癌细胞株中的甲基化状态。结果:受试的3种乳腺癌细胞株仅对5-FU的敏感性有明显差异。其中Bcap-37(IC50:317.386μg/mL)对5-FU相对耐药,而ZR-75-30(IC50:6.676μg/mL)和T47D(IC50:73.076μg/mL)对5-FU相对敏感。23个基因中,有6个基因:ABCC8、CHFR、BMP3B、LOX、PRSS21和RASSF1A在敏感和耐药细胞株中的甲基化状态有差异。其中ABCC8、CHFR和BMP3B在5-FU耐药细胞株中呈相对高甲基化状态,而LOX、PRSS21和RASSF1A则在对5-FU敏感的细胞株中呈相对高甲基化状态。结论:本研究所发现的6个基因的甲基化状态可能与乳腺癌细胞株对5-FU化疗敏感性相关,为下一步进行临床评估和机制探讨提供了依据。 Objective:To identify the abnormal chemosensitivity-associated DNA methylation pattern of CpG islands in the pro- moter region of breast cancer cell lines and provide the evidence for using abnormal DNA methylation in predicting the chemosensitivity in clinic. Methods:The MTT/IC50 assay was used to determine the chemosensifivity of the three breast cancer cell lines ( Beap-37, T47D, and ZR-75-30) to each of the nine anticancer drugs (paclitaxel, docetaxel, vinorelbine, 5-fluorouracil, gemeitabine, epirubiein, mitomycin, ironoteean, and cisplatin). DNA methylation profile of CpG islands in the promoter region of 23 genes of the three breast cancer cell lines was tested by methylafion specific PCR. Results: The sensitivity of the three breast cancer cell lines to 5-FU showed a significant difference. Bcap-37 cells were relatively tolerant to 5-FU (IC50 = 317. 386 μg/mL). ZR-75-30 and T47D were relatively sensitive to 5-FU (ICso = 6. 676 and 73. 076μg/mL, respectively). Out of the 23 genes, the methylation of 6 genes, ABCC8, CHFR, BMP3B, LOX, PRSS21, and RASSF1A, exhibited different patterns between the 5-FU-resistant and sensitive cell lines. The ABCC8, CHFR and BMP3B genes were hypermethylated in the 5-FU-resistant cell line, but LOX, PRSS21, and RASSF1A genes were hypermethylated in the 5-FU-sensitive cell line. Conclusion:There is a promising correlation of the methylation state of 6 genes with the chemosensitivity of the breast cancer cell lines to 5-FU. This study provided the evidence for further clinical evaluation and mechanism exploration.
出处 《肿瘤》 CAS CSCD 北大核心 2009年第1期20-25,共6页 Tumor
基金 上海市科委资助项目(编号:07DJ14074) 上海市肿瘤医院院外合作项目(编号:YWHZ200601)
关键词 乳腺肿瘤 细胞系 DNA甲基化 抗药性 甲基化特异性聚合酶链反应 Breast neoplasms Cell lines DNA nlethylation Drug resistance Methylation specific polymerase chain reaction
  • 相关文献

参考文献20

  • 1TEITZ T, WEI T, VALENTINE M B, et al. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN[J]. Nat Med, 2000, 6(5) : 529-535.
  • 2AKADA M, CRNOGORAC-JURCEVIC T, LATTIMORE S, et al. Intrinsic chemoresistance to gemcitabine is associated with decreased expression of BNIP3 in pancreatic cancer[ J]. Clin Cancer Res, 2005, 11(8) : 3094-3101.
  • 3WORM J, KIRKIN A F, DZHANDZHUGAZYAN K N ,et al. Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells [ J ]. J Biol Chem, 2001,276(43) : 39990-40000.
  • 4HANSEN L T, THYKJAER T, ORNTOFT TF, et al. The role of mismatch repair in small-cell lung cancer cells[ J]. Eur J Cancer, 2003, 39(10) : 1456-1467.
  • 5PLUMB JA, STEELE N, FINN PW, et al. Epigenetic approaches to cancer therapy [ J ]. Biochem Soc Trans, 2004, 32 ( Pt 6 ) : 1095-1097.
  • 6HERMAN J G, GRAFF J R, MYOHANEN S, et al. Methylationspecific PCR: a novel PCR assay for methylation status of CpG islands[ J]. Proc Natl Acad Sci U S A, 1996, 93 ( 18 ) : 9821- 9826.
  • 7YU J, ZHANG H, GU J, et al. Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma [ J ]. BMC Cancer, 2004, 465.
  • 8YU J, ZHU T, WANG Z, et al. A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer[J]. Clin Cancer Res, 2007, 13(24): 7296-7304.
  • 9ASANO T, NAKAMURA K, FUJII H, et al. Altered expression of topoisomerase Ⅱalpha contributes to cross-resistant to etoposide K562/MX2 cell line by aberrant methylation [ J ]. Br J Cancer, 2005, 92(8) : 1486-1492.
  • 10DAVID GL,YEGNASUBRAMANIAN S,KUMAR A, et al. MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-azacytidine[J]. Cancer Biol Ther, 2004, 3(6) : 540-548.

同被引文献65

  • 1蒋静,唐良萏,阳志宁.p53基因与卵巢癌耐药的关系[J].实用医学杂志,2007,23(10):1588-1590. 被引量:4
  • 2黄朝晖,李莉华,杨帆,刘志辉,胡瑜,宋明旭,任金冬.粪便DNA甲基化分析在结直肠癌诊断中的应用价值[J].中华检验医学杂志,2007,30(6):617-620. 被引量:8
  • 3Jemal A,Siegel R,Ward E,et aL Cancer statistics,2009.CA Cancer J Clin,2009,59:225-249.
  • 4Baylin SB,Ohm JE.Epigenetic gene silencing in cancer;a mechanism for early oncogenic pathway addiction? Nat Rev Cancer,2006,6:107-116.
  • 5Zhu J,Yao X.Use of DNA methylation for cancer detection:promises and challenges.Int J Biochem Cell Biol,2009,41:147-154.
  • 6Cottrell SE,Laird PW.Sensitive detection of DNA methylation.Ann N Y Acad Sci,2003,983:120-130.
  • 7Plumb JA,Steele N,Finn PW,et al.Epigenetic approaches to cancer therapy.Biochem Soc Trans,2004,32:1095-1097.
  • 8Teitz T,Wei T,Valentine MB,et al.Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN.Nat Med,2000,6:529-535.
  • 9Worm J,Kirkin AF,Dzhandzhugazyan KN,et al.Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistanl human breast cancer cells.J Biol Chem,2001,276:39990-40000.
  • 10David CL,Yegnasubramanian S,Kumar A,et al.MDR1 promoter hypermethylation in MCF-7 human breast cancer cells:changes in chromatin structure induced by treatment with 5-Aza-cytidine.Cancer Biol Ther,2004,3:540-548.

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部